Pazopanib Catalog No.:M7809-10 CAS Number: 2378801-85-3

CAS Number: 2378801-85-3

GSK2983559-active metabolite

Mathapati S

MK-1775 was orally dosed to mice at 20 mg/Kg once per day

suggesting potentially a long-lasting effect of S3I-201 on tumor growth

Pazopanib Catalog No.:M7809-10 CAS Number: 2378801-85-3Pazopanib is an approved drug, is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR) 1, 2 and 3, c kit and platelet derived growth factor receptor (PDGF R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated. Check for active clinical trials or closed clinical trials